Search academic texts

Information × Registration Number 2120U005270, Article popup.category Thesis Title popup.author popup.publication 01-01-2020 popup.source_user Сумський державний університет popup.source https://essuir.sumdu.edu.ua/handle/123456789/78011 popup.publisher Sumy State University Description The review is devoted to the current biomedical direction in cell-replacement therapy - therapeutic cloning, which is the most universal approach for obtaining patient-specific embryonic stem cell lines (hESC) with tremendous potential in maintaining and restoring human health. Now the main sources of stem cells directly for biomedical work are stem cells from umbilical cord blood and adult stem cells. Both sources have serious limitations: umbilical cord blood stem cells are autogenous only to the newly born, and receiving stem cells from the patient himself is unsafe for him. In addition, in general opinion, the potential for differentiation in these cells is lower than in ESCs. Obviously, the most versatile and reliable source of human stem cell (SC) production is through cloning technology. popup.nrat_date 2025-05-12 Close